Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up

European Journal of Preventive Cardiology

Volumn 23, Issue 5, 2016, Pages 552-558

  Van Dijk, Milan R ^a   Utens, Elisabeth M W J ^b   Dulfer, Karolijn ^b   Al Qezweny, Mustafa N A ^a   Van Geuns, Robert Jan ^a   Daemen, Joost ^a   Van Domburg, Ron T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

all cause mortality; anxiety; coronary artery disease; Depression; percutaneous coronary intervention

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ANXIETY; ARTICLE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DEPRESSION; FEMALE; FOLLOW UP; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STABLE ANGINA PECTORIS; SURVIVAL RATE; UNSTABLE ANGINA PECTORIS; ADVERSE EFFECTS; AGED; COMORBIDITY; COMPARATIVE STUDY; EPIDEMIOLOGY; KAPLAN MEIER METHOD; NETHERLANDS; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

AGED; ANXIETY; COMORBIDITY; CORONARY ARTERY DISEASE; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NETHERLANDS; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84958692867     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487315571889     Document Type: Article

References (34)

1. Windecker S, Stortecky S, Stefanini GG, et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: Network meta-analysis. BMJ 2014; 348: g3859-g3859.
2. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention. Lancet 2013; 382: 339-352.
3. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
4. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003; 107: 1303-1307.
5. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364: 937-952.
6. Burg MM, Benedetto MC, Soufer R,. Depressive symptoms and mortality two years after coronary artery bypass graft surgery (CABG) in men. Psychosom Med 2003; 65: 508-510.
7. Connerney I, Sloan RP, Shapiro PA, et al. Depression is associated with increased mortality 10 years after coronary artery bypass surgery. Psychosom Med 2010; 72: 874-881.
8. Lesperance F, Frasure-Smith N, Talajic M, et al. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002; 105: 1049-1053.
9. Parakh K, Thombs BD, Fauerbach JA, et al. Effect of depression on late (8 years) mortality after myocardial infarction. Am J Cardiol 2008; 101: 602-606.
10. Barth J, Schumacher M, Herrmann-Lingen C,. Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom Med 2004; 66: 802-813.
11. Meijer A, Conradi HJ, Bos EH, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011; 33: 203-216.
12. Nicholson A, Kuper H, Hemingway H,. Depression as an aetiologic and prognostic factor in coronary heart disease: A meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-2774.
13. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis. Psychosom Med 2004; 66: 814-822.
14. Frasure-Smith N, Lesperance F, Talajic M,. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999-1005.
15. Grace SL, Abbey SE, Kapral MK, et al. Effect of depression on five-year mortality after an acute coronary syndrome. Am J Cardiol 2005; 96: 1179-1185.
16. Pedersen SS, Denollet J, Daemen J, et al. Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. J Psychosom Res 2007; 62: 455-461.
17. Barefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996; 78: 613-617.
18. Welin C, Lappas G, Wilhelmsen L,. Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med 2000; 247: 629-639.
19. Roest AM, Martens EJ, Denollet J, et al. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: A meta-analysis. Psychosom Med 2010; 72: 563-569.
20. Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the 'real world': The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 2004; 109: 190-195.
21. Rumsfeld JS, Magid DJ, Plomondon ME, et al. Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia. J Am Coll Cardiol 2003; 41: 1732-1738.
22. Goodyear MD, Krleza-Jeric K, Lemmens T,. The Declaration of Helsinki. BMJ 2007; 335: 624-625.
23. Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
24. Spinhoven P, Ormel J, Sloekers PP, et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997; 27: 363-370.
25. Kessler RC, Nelson CB, McGonagle KA, et al. Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey. Br J Psychiatry Suppl 1996, pp. 17-30.
26. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289: 3095-3105.
27. Pigott TA,. Anxiety disorders in women. Psychiatr Clin North Am 2003; 26: 621-672, vi-vii.
28. Damen NL, Versteeg H, Boersma E, et al. Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: Results from the RESEARCH registry. Int J Cardiol 2013; 167: 2496-2501.
29. Lichtman JH, Froelicher ES, Blumenthal JA, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: Systematic review and recommendations: A scientific statement from the American Heart Association. Circulation 2014; 129: 1350-1369.
30. Clark LA, Watson D,. Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. J Abnorm Psychol 1991; 100: 316-336.
31. Abrignani MG, Renda N, Abrignani V, et al. Panic disorder, anxiety, and cardiovascular diseases. Clinical Neuropsychiatry 2014; 11: 130-144.
32. Versteeg H, Hoogwegt MT, Hansen TB, et al. Depression, not anxiety, is independently associated with 5-year hospitalizations and mortality in patients with ischemic heart disease. J Psychosom Res 2013; 75: 518-525.
33. Meyer T, Hussein S, Lange HW, et al. Anxiety is associated with a reduction in both mortality and major adverse cardiovascular events five years after coronary stenting. Eur J Prev Cardiol 2015; 22: 75-82.
34. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.